Contact
Please use this form to send email to PR contact of this press release:
Human medicines European public assessment report (EPAR): NexoBrid, concentrate of proteolytic enzymes enriched in bromelain, Date of authorisation: 18/12/2012, Revision: 16, Status: Authorised
TO: